TickerFactsScreenerDevelopers

Viridian Therapeutics, Inc.\DE (VRDN) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $5.0K2014: $266.0K2015: $123.0K2016: $250.0K2017: $246.0K2018: $445.0K2019: $84.0K2020: $42.0K2021: $338.0K2022: $797.0K2023: $898.0K2024: $511.0K2025: $495.0K$495.0K
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$495.0K-3.1%
2024$511.0K-43.1%
2023$898.0K+12.7%
2022$797.0K+135.8%
2021$338.0K+704.8%
2020$42.0K-50.0%
2019$84.0K-81.1%
2018$445.0K+80.9%
2017$246.0K-1.6%
2016$250.0K+103.3%
2015$123.0K-53.8%
2014$266.0K+5220.0%
2013$5.0K—